Join Fluidigm and Visiopharm at the Imaging Mass Cytometry Summit for a demonstrtaion of the uitility of Visiopharm’s Phenotyping and Deep Learning toolbox for advanced multiplex phenotype analysis of Hyperion Imaging System multiplexed data sets.

We will provide an overview of Visiopharm’s flexible and intuitive Deep Learning and Advanced Phenotyping solutions to provide a comprehensive analysis of highly multiplexed IMC datasets. Specifically, we will demonstrate Visiopharm’s approach to and scope of cell segmentation and phenotyping algortithm development using real world IMC examples.

• • Tissue mining to enhance anlysis

• • Cell segmentation by deep learning

• • Robust multiplex phenotyping

• • Integration supported phenotyping

Brit Boehmer, Account Executive, Sales US, Visiopharm

Brit Boehmer is an Account Executive for the US West based in Denver, CO. He has a master’s and Ph.D. in physiology from Oklahoma State University and completed postdoctoral research in reproduction, nutrition and fetal growth. Brit joined Visiopharm in 2020 and supports clients with pre-sale APP development and advice on image analysis and histopathology workflows.